Gut Liver.
2018 Mar;12(2):173-182. 10.5009/gnl17163.
Methylation Status of Transcriptional Modulatory Genes Associated with Colorectal Cancer in Northeast China
- Affiliations
-
- 1Department of Epidemiology, Public Health College, Harbin Medical University, Harbin, China. zhao_yashuang@263.net, liuyupenf@126.com
- 2Department of General Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, China. qiangchi61@126.com
- KMID: 2429072
- DOI: http://doi.org/10.5009/gnl17163
Abstract
- BACKGROUND/AIMS
Methylation status plays a causal role in carcinogenesis in targeted tissues. However, the relationship between the DNA methylation status of multiple genes in blood leukocytes and colorectal cancer (CRC) susceptibility as well as interactions between dietary factors and CRC risks are unclear.
METHODS
We performed a case-control study with 466 CRC patients and 507 cancer-free controls to investigate the association among the methylation status of individual genes, multiple CpG site methylation (MCSM), multiple CpG site heterogeneous methylation and CRC susceptibility. Peripheral blood DNA methylation levels were detected by performing methylation-sensitive high-resolution melting.
RESULTS
Total heterogeneous methylation of CA10 and WT1 conferred a significantly higher risk of CRC (adjusted odds ratio [OR(adjusted)], 5.445; 95% confidence interval [CI], 3.075 to 9.643; OR(adjusted), 1.831; 95% CI, 1.100 to 3.047; respectively). Subjects with high-level MCSM (MCSM-H) status demonstrated a higher risk of CRC (OR(adjusted), 4.318; 95% CI, 1.529 to 12.197). Additionally, interactions between the high-level intake of fruit and CRH, WT1, and MCSM on CRC were statistically significant.
CONCLUSIONS
The gene methylation status of blood leukocytes may be associated with CRC risk. MCSM-H of blood leukocytes was associated with CRC, especially in younger people. Some dietary factors may affect hypermethylation status and influence susceptibility to CRC.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- In silico Identification of SFRP1 as a Hypermethylated Gene in Colorectal Cancers
- Transcription Silencing and CpGs Hypermethylation as Therapeutic Gene Editing in Clinical Colorectal Adenocarcinoma Repression
- CpG Island Methylation in Familial Colorectal Cancer Patients Not Fulfilling the Amsterdam Criteria
- Aberrant Promoter Methylation of the Vimentin Gene in Colorectal Cancer Associated with the Adenoma-Carcinoma Sequence
- Epigenetic Changes (Aberrant DNA Methylation) in Colorectal Neoplasia
